Go Pro

Alignment Healthcare (ALHC) Competitors

Alignment Healthcare logo
$7.86 -0.13 (-1.63%)
Closing price 04:00 PM Eastern
Extended Trading
$7.85 -0.01 (-0.08%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ALHC vs. OSCR, HQY, CLOV, UNH, and ELV

Should you buy Alignment Healthcare stock or one of its competitors? Alignment Healthcare's main competitors and comparable companies include Oscar Health (OSCR), HealthEquity (HQY), Clover Health Investments (CLOV), UnitedHealth Group (UNH), and Elevance Health (ELV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Alignment Healthcare compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Alignment Healthcare (NASDAQ:ALHC) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Oscar Health has a net margin of 3.60% compared to Alignment Healthcare's net margin of 0.89%. Oscar Health's return on equity of 38.45% beat Alignment Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health3.60% 38.45% 6.76%
Alignment Healthcare 0.89%20.02%3.46%

Oscar Health presently has a consensus target price of $33.90, indicating a potential upside of 11.11%. Alignment Healthcare has a consensus target price of $23.60, indicating a potential upside of 200.25%. Given Alignment Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.31
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

Alignment Healthcare has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.80-$443.15M$1.4021.79
Alignment Healthcare$3.95B0.41-$720K$0.1941.37

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by company insiders. Comparatively, 5.2% of Alignment Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Oscar Health has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market. Comparatively, Alignment Healthcare has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market.

In the previous week, Oscar Health had 5 more articles in the media than Alignment Healthcare. MarketBeat recorded 21 mentions for Oscar Health and 16 mentions for Alignment Healthcare. Oscar Health's average media sentiment score of 0.36 beat Alignment Healthcare's score of 0.30 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
5 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alignment Healthcare
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Oscar Health beats Alignment Healthcare on 11 of the 17 factors compared between the two stocks.

How does Alignment Healthcare compare to HealthEquity?

Alignment Healthcare (NASDAQ:ALHC) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, Alignment Healthcare had 12 more articles in the media than HealthEquity. MarketBeat recorded 16 mentions for Alignment Healthcare and 4 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.69 beat Alignment Healthcare's score of 0.30 indicating that HealthEquity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alignment Healthcare
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
HealthEquity
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alignment Healthcare presently has a consensus price target of $23.60, suggesting a potential upside of 200.25%. HealthEquity has a consensus price target of $112.20, suggesting a potential upside of 24.13%. Given Alignment Healthcare's higher possible upside, research analysts plainly believe Alignment Healthcare is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64
HealthEquity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.92

Alignment Healthcare has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market.

HealthEquity has a net margin of 17.36% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
Alignment Healthcare0.89% 20.02% 3.46%
HealthEquity 17.36%15.33%9.51%

HealthEquity has lower revenue, but higher earnings than Alignment Healthcare. HealthEquity is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alignment Healthcare$3.95B0.41-$720K$0.1941.37
HealthEquity$1.31B5.69$215.20M$2.7732.63

Summary

HealthEquity beats Alignment Healthcare on 10 of the 17 factors compared between the two stocks.

How does Alignment Healthcare compare to Clover Health Investments?

Alignment Healthcare (NASDAQ:ALHC) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

Alignment Healthcare has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, suggesting that its share price is 147% more volatile than the broader market.

Alignment Healthcare has a net margin of 0.89% compared to Clover Health Investments' net margin of -0.74%. Alignment Healthcare's return on equity of 20.02% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Alignment Healthcare0.89% 20.02% 3.46%
Clover Health Investments -0.74%-4.20%-2.28%

86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Alignment Healthcare currently has a consensus target price of $23.60, suggesting a potential upside of 200.25%. Clover Health Investments has a consensus target price of $4.75, suggesting a potential upside of 3.94%. Given Alignment Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Alignment Healthcare is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

In the previous week, Alignment Healthcare had 7 more articles in the media than Clover Health Investments. MarketBeat recorded 16 mentions for Alignment Healthcare and 9 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.77 beat Alignment Healthcare's score of 0.30 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alignment Healthcare
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Clover Health Investments
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alignment Healthcare has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alignment Healthcare$3.95B0.41-$720K$0.1941.37
Clover Health Investments$1.92B1.26-$85.55M-$0.05N/A

Summary

Alignment Healthcare beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Alignment Healthcare compare to UnitedHealth Group?

UnitedHealth Group (NYSE:UNH) and Alignment Healthcare (NASDAQ:ALHC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

UnitedHealth Group has a net margin of 3.14% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group3.14% 16.53% 5.43%
Alignment Healthcare 0.89%20.02%3.46%

UnitedHealth Group presently has a consensus price target of $456.56, indicating a potential upside of 23.14%. Alignment Healthcare has a consensus price target of $23.60, indicating a potential upside of 200.25%. Given Alignment Healthcare's higher probable upside, analysts plainly believe Alignment Healthcare is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
7 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.78
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

UnitedHealth Group has higher revenue and earnings than Alignment Healthcare. UnitedHealth Group is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.74$12.06B$15.5423.86
Alignment Healthcare$3.95B0.41-$720K$0.1941.37

In the previous week, UnitedHealth Group had 9 more articles in the media than Alignment Healthcare. MarketBeat recorded 25 mentions for UnitedHealth Group and 16 mentions for Alignment Healthcare. UnitedHealth Group's average media sentiment score of 0.65 beat Alignment Healthcare's score of 0.30 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
12 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Alignment Healthcare
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 0.2% of UnitedHealth Group shares are held by insiders. Comparatively, 5.2% of Alignment Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

UnitedHealth Group has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Alignment Healthcare has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market.

Summary

UnitedHealth Group beats Alignment Healthcare on 12 of the 17 factors compared between the two stocks.

How does Alignment Healthcare compare to Elevance Health?

Alignment Healthcare (NASDAQ:ALHC) and Elevance Health (NYSE:ELV) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

Elevance Health has a net margin of 2.47% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Alignment Healthcare0.89% 20.02% 3.46%
Elevance Health 2.47%14.64%5.22%

86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Alignment Healthcare had 10 more articles in the media than Elevance Health. MarketBeat recorded 16 mentions for Alignment Healthcare and 6 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.78 beat Alignment Healthcare's score of 0.30 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alignment Healthcare
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Elevance Health
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alignment Healthcare has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Alignment Healthcare. Elevance Health is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alignment Healthcare$3.95B0.41-$720K$0.1941.37
Elevance Health$199.13B0.43$5.66B$22.5017.69

Alignment Healthcare presently has a consensus price target of $23.60, indicating a potential upside of 200.25%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 10.78%. Given Alignment Healthcare's higher possible upside, equities analysts clearly believe Alignment Healthcare is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Summary

Elevance Health beats Alignment Healthcare on 10 of the 16 factors compared between the two stocks.

Get Alignment Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALHC vs. The Competition

MetricAlignment HealthcareHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.66B$9.76B$7.32B$13.29B
Dividend YieldN/A2.59%2.52%12.57%
P/E Ratio41.3734.44274.0125.69
Price / Sales0.414.91667.9494.08
Price / Cash52.90122.1177.8052.76
Price / Book8.735.2010.446.32
Net Income-$720K$315.70M$3.49B$359.73M
7 Day Performance-9.76%-1.36%0.51%1.35%
1 Month Performance-40.27%-2.74%-3.38%-3.68%
1 Year Performance-53.87%11.52%16.04%5.56%

Alignment Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALHC
Alignment Healthcare
4.2588 of 5 stars
$7.86
-1.6%
$23.60
+200.3%
-53.2%$1.66B$3.95B41.371,849
OSCR
Oscar Health
4.548 of 5 stars
$33.86
+3.3%
$26.22
-22.5%
+65.7%$10.11B$15.32B24.182,305
HQY
HealthEquity
4.5149 of 5 stars
$96.04
-0.2%
$111.87
+16.5%
-4.4%$7.96B$1.36B34.672,814
CLOV
Clover Health Investments
2.9488 of 5 stars
$5.10
+5.8%
$4.75
-6.9%
+55.7%$2.56B$2.48BN/A724
UNH
UnitedHealth Group
4.9635 of 5 stars
$383.23
+1.1%
$456.56
+19.1%
+9.2%$340.27B$447.57B24.66390,000

Related Companies and Tools


This page (NASDAQ:ALHC) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners